Cargando…
Nebulised hypertonic saline (3 %) among children with mild to moderately severe bronchiolitis - a double blind randomized controlled trial
BACKGROUND: To Assess the efficacy of nebulised hypertonic saline (HS) (3 %) among children with mild to moderately severe bronchiolitis. METHODS: Infants aged 6 weeks to 24 months, with a first episode of wheezing and Clinical Severity scores (Arch Dis Child 67:289-93, 1992) between 1 and 8, were e...
Autores principales: | Khanal, Aayush, Sharma, Arun, Basnet, Srijana, Sharma, Pushpa Raj, Gami, Fakir Chandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4644020/ https://www.ncbi.nlm.nih.gov/pubmed/26357896 http://dx.doi.org/10.1186/s12887-015-0434-4 |
Ejemplares similares
-
SABRE: a multicentre randomised control trial of nebulised hypertonic saline in infants hospitalised with acute bronchiolitis
por: Everard, Mark L, et al.
Publicado: (2014) -
Comparison of nebulised 3% hypertonic saline with ipratropium bromide in treatment of children with bronchiolitis: a randomized control trial
por: Naveed, Hina, et al.
Publicado: (2023) -
Nebulised 3% hypertonic saline versus 0.9% saline for treating patients hospitalised with acute bronchiolitis: protocol for a randomised, double-blind, multicentre trial
por: Szupieńko, Sara, et al.
Publicado: (2023) -
The cost-effectiveness of hypertonic saline inhalations for infant bronchiolitis
por: Buendía, Jefferson Antonio, et al.
Publicado: (2020) -
Epinephrine Improves the Efficacy of Nebulized Hypertonic Saline in Moderate Bronchiolitis: A Randomised Clinical Trial
por: Flores-González, J. Carlos, et al.
Publicado: (2015)